Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05751278 · ClinicalTrials.gov registry record · NA
Cryoprobe Versus Forceps for Transbronchial Biopsy
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 500
- Enrollment target
NCT05751278: Completed NA study, sponsored by Johns Hopkins University.
NCT05751278 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05751278, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of transbronchial biopsy done by a 1.1mm cryoprobe versus the standard 2.0mm forceps.
Primary Outcome
Diagnostic Yield as Assessed by Number of Patients for Which the Procedure \[Cryobiopsy or Forceps\] Led to a Diagnosis.
Interventions
- DEVICE ERBECRYO® 2 Cryosurgical Unit and Accessories - K190651
- DEVICE Radial Jaw 4 Pulmonary Biopsy Forceps
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-02-27 |
| Est. Completion | 2026-03-02 |
| Phase | NA |
What the finished NCT05751278 record still lists
NCT05751278 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 2 interventions - of which ERBECRYO® 2 Cryosurgical Unit and Accessories - K190651 is the first listed.
NCT05751278 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05751278 about?
NCT05751278 is a clinical study titled "Cryoprobe Versus Forceps for Transbronchial Biopsy". The purpose of this study is to compare the effectiveness of transbronchial biopsy done by a 1.1mm cryoprobe versus the standard 2.0mm forceps.
What is the current status of trial NCT05751278?
This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2023-02-27. Estimated completion is 2026-03-02.
What interventions are being tested in trial NCT05751278?
The interventions under investigation include: ERBECRYO® 2 Cryosurgical Unit and Accessories - K190651 (DEVICE), Radial Jaw 4 Pulmonary Biopsy Forceps (DEVICE).
Who is sponsoring clinical trial NCT05751278?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05751278's enrollment target sits among peer trials
500 193rd of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI